Health CanadaGeneral Alert
Archived - Important safety information regarding Serevent® in Asthma (salmetero...
Published: February 23, 2009Recall ID: 24249Category: generalCountry: Canada
Product Description & Identification
Archived - Important safety information regarding Serevent® in Asthma (salmeterol xinafoate) and cessation of the SMART (Salmeterol Multi-center Asthma Research Trial) - GlaxoSmithKline Inc.
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24249 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/archived-important-safety-information-regarding-sereventr-asthma-salmeterol-xinafoate |
| Title | Archived - Important safety information regarding Serevent® in Asthma (salmeterol xinafoate) and cessation of the SMART (Salmeterol Multi-center Asthma Research Trial) - GlaxoSmithKline Inc. |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2009-02-23 |
| Organization | Marketed health products |